Pharmacogenomics: Post COVID-19 Expansion of Molecular Testing

Explore the impact of COVID-19 on molecular diagnostic technologies and the expansion of RT-PCR testing in this 37-minute panel presentation webinar. Delve into how the rapid emergence of SARS-CoV-2 led to significant advancements in diagnostic approaches, with real-time RT-PCR becoming the primary method for detecting the virus. Discover why traditional culture-based methods proved insufficient for COVID-19 diagnosis and how the sensitivity and specificity of molecular techniques created opportunities for new product development. Learn about the potential for laboratories to apply RT-PCR testing beyond COVID-19, including its use in diagnosing other infectious diseases and genetic testing such as pharmacogenomics. Gain insights into the evolving landscape of molecular testing and its implications for future diagnostic practices. Earn PACE credits by watching the webinar and following the provided instructions. Connect with Labroots on various social media platforms for more scientific content and updates.

Panel Presentation: Pharmacogenomics: Post COVID-19 Expansion of Molecular Testing